What shareholders can do to beat the market with FTC Solar Inc (FTCI) stock

FTC Solar Inc (NASDAQ: FTCI) closed the day trading at $0.41 down -9.86% from the previous closing price of $0.45. On the day, 534428 shares were traded.

Ratios:

For a better understanding of FTCI, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.80 and its Current Ratio is at 1.98. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.

On November 09, 2023, Northland Capital Downgraded its rating to Market Perform which previously was Outperform but kept the price unchanged to $0.65.

UBS Downgraded its Buy to Neutral on August 15, 2023, whereas the target price for the stock was revised from $4 to $2.50.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 26 ’24 when Chatila Ahmad R bought 97,400 shares for $0.51 per share. The transaction valued at 49,674 led to the insider holds 967,458 shares of the business.

Chatila Ahmad R bought 92,600 shares of FTCI for $50,930 on Mar 22 ’24. The Director now owns 870,058 shares after completing the transaction at $0.55 per share. On Mar 21 ’24, another insider, Cook Patrick, who serves as the Chief Commercial Officer of the company, sold 23,000 shares for $0.58 each. As a result, the insider received 13,340 and left with 1,222,205 shares of the company.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 0.40 while its Price-to-Book (P/B) ratio in mrq is 0.81.

Stock Price History:

Over the past 52 weeks, FTCI has reached a high of $3.87, while it has fallen to a 52-week low of $0.28.

Shares Statistics:

A total of 125.45M shares are outstanding, with a floating share count of 55.46M. Insiders hold about 55.63% of the company’s shares, while institutions hold 26.87% stake in the company.

Earnings Estimates

Current recommendations for the stock of the company come from Intra-Cellular Therapies Inc. analysts. The consensus estimate for the next quarter is $4.56, with high estimates of $71.72 and low estimates of $25.28.

Analysts are recommending an EPS of between $Industrials and $Energy for the fiscal current year, implying an average EPS of $Basic Materials.

Most Popular

[the_ad id="945"]